Evidence map›Paper›PMID 27784327›Full record

ReviewGenome medicine2016

Integrating cancer genomic data into electronic health records.

Jeremy L Warner, Sandeep K Jain, Mia A Levy

Abstract readReview
In one paragraph

Review in Genome medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Impact of integrating genomic data into the electronic health record on genetics care delivery.Genetics in medicine : official journal of the American College of Medical Genetics · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. A qualitative study of prevalent laboratory information systems and data communication patterns for genetic test reporting.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  15. Review
  16. Patients dispensed medications with actionable pharmacogenomic biomarkers: rates and characteristics.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jeremy L WarnerDepartment of Medicine, Division of Hematology/Oncology, Vanderbilt University, Nashville, TN, USA. jeremy.warner@vanderbilt.edu.
Sandeep K JainDepartment of Biomedical Informatics, Vanderbilt University, Nashville, TN, 37232, USA.
Mia A LevyDepartment of Medicine, Division of Hematology/Oncology, Vanderbilt University, Nashville, TN, USA.

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Integrated, Individualized, Intelligent Prescribing (I3P)U01HG007253 · NHGRI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI LEVY, MIA A., PETERSON, JOSEPH F. · 2014 to 2018
$4.6M
NCI NIH HHS P30 CA068485NHGRI NIH HHS U01 HG007253
6 · The paper itself

Abstract

The rise of genomically targeted therapies and immunotherapy has revolutionized the practice of oncology in the last 10-15 years. At the same time, new technologies and the electronic health record (EHR) in particular have permeated the oncology clinic. Initially designed as billing and clinical documentation systems, EHR systems have not anticipated the complexity and variety of genomic information that needs to be reviewed, interpreted, and acted upon on a daily basis. Improved integration of cancer genomic data with EHR systems will help guide clinician decision making, support secondary uses, and ultimately improve patient care within oncology clinics. Some of the key factors relating to the challenge of integrating cancer genomic data into EHRs include: the bioinformatics pipelines that translate raw genomic data into meaningful, actionable results; the role of human curation in the interpretation of variant calls; and the need for consistent standards with regard to genomic and clinical data. Several emerging paradigms for integration are discussed in this review, including: non-standardized efforts between individual institutions and genomic testing laboratories; "middleware" products that portray genomic information, albeit outside of the clinical workflow; and application programming interfaces that have the potential to work within clinical workflow. The critical need for clinical-genomic knowledge bases, which can be independent or integrated into the aforementioned solutions, is also discussed.

Indexed as

Systems IntegrationDecision Support Systems, ClinicalElectronic Health RecordsGenomicsHealth Information SystemsHumansMedical InformaticsMedical OncologyMedical Records Systems, ComputerizedNeoplasms

Identifiers

PMID27784327
PMCPMC5081968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.